Neogenomics Inc (NASDAQ:NEO)
| 3.64 Data as of May 17 |  +0.02 / +0.55%Today’s Change | 1.55 Today|||52-Week Range 4.20 | +46.77% Year-to-Date |
Latest NEO News | Press Releases
No recent news for Neogenomics Inc.
Today’s Trading
| Previous close | 3.62 |
| Today’s open | 3.65 |
| Day’s range | -- - -- |
| Volume | 16,851 |
| Average volume (3 months) | 222,596 |
| Market cap | $177.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +37.68% |
| P/E ratio | NM |
| Price/Sales | 1.87 |
| Price/Book | 17.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FCSCFibrocell Science In... | +0.30 | +6.38% |
| MGMistras Group Inc | -0.02 | -0.10% |
| CLDXCelldex Therapeutics... | +0.29 | +2.34% |
| CVDCovance Inc | +0.45 | +0.59% |
Data as of 4:05pm ET, 05/17/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $59.9M |
| Annual profit (last year) | $65.0K |
| Net profit margin | 0.11% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
Chairman & Chief Executive Officer Douglas M. VanOort, CPA |
Chief Financial Officer George A. Cardoza, MBA |
Corporate headquarters Fort Myers, Florida |
Forecasts
